Discovering and Optimizing First-in-Class Biologics
The Engineering stream profiles the rapid advancements in biologic drug development and provides unparalleled knowledge and collaboration opportunities. This year’s list of hot topics includes deep sequencing of antibody repertoires, single cell
analysis, yeast and phage display for antibody discovery, tools for designing “smart” antibodies including AI and machine learning, improving targeting specificity, overcoming liabilities, next generation libraries, targeting membrane
proteins, engineering bispecific antibodies for oncology and beyond. Plan to attend and learn why this has become the industry’s leading event in biotherapeutics.
Conferences Include:
August 31 - September 1
Display of Antibodies
September 2-3
Engineering Antibodies
September 3-4
Engineering Bispecific Antibodies
Keynote Speakers Include:
Paul J. Carter, PhD, Senior Staff Scientist & Senior Director, Antibody Engineering, Genentech
David Gifford, PhD, Professor,
Computer Science and Biological Engineering, MIT
Dimitris Skokos, PhD, Director,
Immune & Inflammatory Diseases, Regeneron Pharmaceuticals